[1]Luo J, Wang H, Peng J, et al. Rate of Adjacent Segment Degeneration of Cervical Disc Arthroplasty Versus Fusion Meta-Analysis of Randomized Controlled Trials. World Neurosurg. 2018;113:225-231.[2]Crevensten G, Walsh AJ, Ananthakrishnan D, et al. Intervertebral disc cell therapy for regeneration: mesenchymal stem cell implantation in rat intervertebral discs. Ann Biomed Eng. 2004;32(3):430-434.[3]Tang R, Jing L, Willard VP, et al. Differentiation of human induced pluripotent stem cells into nucleus pulposus-like cells. Stem Cell Res Ther. 2018;9(1):61.[4]Steck E, Bertram H, Abel R, et al. Induction of intervertebral disc-like cells from adult mesenchymal stem cells. Stem Cells. 2005;23(3):403-411.[5]Hu J, Deng G, Tian Y, et al. An in vitro investigation into the role of bone marrow?derived mesenchymal stem cells in the control of disc degeneration. Mol Med Rep. 2015;12(4): 5701-5708.[6]Lee EH, Hui JH. The potential of stem cells in orthopaedic surgery. J Bone Joint Surg Br. 2006;88(7):841-851.[7]Vadalà G, Studer RK, Sowa G, et al. Coculture of bone marrow mesenchymal stem cells and nucleus pulposus cells modulate gene expression profile without cell fusion. Spine (Phila Pa 1976). 2008;33(8):870-876.[8]Peroglio M, Douma LS, Caprez TS, et al. Intervertebral disc response to stem cell treatment is conditioned by disc state and cell carrier: An ex vivo study. J Orthop Translat. 2017;9: 43-51.[9]Ishiguro H, Kaito T, Yarimitsu S, et al. Intervertebral disc regeneration with an adipose mesenchymal stem cell-derived tissue-engineered construct in a rat nucleotomy model. Acta Biomater. 2019;87:118-129.[10]Bach FC, Tellegen AR, Beukers M, et al. Biologic canine and human intervertebral disc repair by notochordal cell-derived matrix: from bench towards bedside. Oncotarget. 2018;9(41): 26507-26526.[11]de Vries S, Doeselaar MV, Meij B, et al. Notochordal Cell Matrix As a Therapeutic Agent for Intervertebral Disc Regeneration. Tissue Eng Part A. 2019;25(11-12):830-841.[12]Lin X, Fang X, Wang Q, et al. Decellularized allogeneic intervertebral disc: natural biomaterials for regenerating disc degeneration. Oncotarget. 2016;7(11):12121-12136.[13]Saggese T, Thambyah A, Wade K, et al. Differential Response of Bovine Mature Nucleus Pulposus and Notochordal Cells to Hydrostatic Pressure and Glucose Restriction. Cartilage. 2018:1947603518775795.[14]Li G, Yu F, Lei T, et al.Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategies.Neural Regen Res. 2016; 11(6):1015-1024.[15]Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276(5309):71-74.[16]Vadalà G, Russo F, Ambrosio L, et al. Stem cells sources for intervertebral disc regeneration. World J Stem Cells. 2016; 8(5):185-201.[17]Steffen F, Smolders LA, Roentgen AM, et al. Bone Marrow-Derived Mesenchymal Stem Cells as Autologous Therapy in Dogs with Naturally Occurring Intervertebral Disc Disease: Feasibility, Safety, and Preliminary Results. Tissue Eng Part C Methods. 2017;23(11):643-651.[18]Marcucio RS, Nauth A, Giannoudis PV, et al. Stem Cell Therapies in Orthopaedic Trauma. J Orthop Trauma. 2015;29 Suppl 12:S24-27.[19]Deng P, Torrest A, Pollock K, et al.Clinical trial perspective for adult and juvenile Huntington's disease using genetically- engineered mesenchymal stem cells.Neural Regen Res. 2016;11(5):702-705.[20]Zeng Y, Feng S, Liu W, et al. Preconditioning of mesenchymal stromal cells toward nucleus pulposus-like cells by microcryogels-based 3D cell culture and syringe-based pressure loading system. J Biomed Mater Res B Appl Biomater. 2017;105(3):507-520.[21]Han XB, Zhang YL, Li HY, et al. Differentiation of Human Ligamentum Flavum Stem Cells Toward Nucleus Pulposus-Like Cells Induced by Coculture System and Hypoxia. Spine (Phila Pa 1976). 2015;40(12):E665-674.[22]Vadalà G, Sowa G, Hubert M, et al. Mesenchymal stem cells injection in degenerated intervertebral disc: cell leakage may induce osteophyte formation. J Tissue Eng Regen Med. 2012; 6(5):348-355.[23]Smolders LA, Bergknut N, Grinwis GC, et al. Intervertebral disc degeneration in the dog. Part 2: chondrodystrophic and non-chondrodystrophic breeds. Vet J. 2013;195(3):292-299.[24]Bergknut N, Rutges JP, Kranenburg HJ, et al. The dog as an animal model for intervertebral disc degeneration. Spine (Phila Pa 1976). 2012;37(5):351-358.[25]Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.[26]Salzig D, Schmiermund A, Gebauer E, et al. Influence of porcine intervertebral disc matrix on stem cell differentiation. J Funct Biomater. 2011;2(3):155-172.[27]Potier E, de Vries S, van Doeselaar M, et al. Potential application of notochordal cells for intervertebral disc regeneration: an in vitro assessment. Eur Cell Mater. 2014;28:68-80.[28]Vujovic S, Henderson S, Presneau N, et al. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol. 2006;209(2):157-165. |